Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Solitary pulmonary nodule Stories

2013-09-05 11:09:25

Evidence-based recommendations available in October issue of JTO Lung cancer is the most common cause of cancer death in Ontario.  Screening for lung cancer using low-dose computed tomography (LDCT) has been the subject of many research studies since the 1990s. The National Lung Screening Trial compared LDCT with chest radiograph in high-risk populations and found a 20 percent reduction in lung cancer mortality at 6 years with LDCT after an initial scan and two annual rounds of screening....

2013-09-04 20:21:38

VANCOUVER, Sept. 4, 2013 /CNW/ - A Terry Fox Research Institute(TFRI)-led study has developed a new clinical risk calculator software that accurately classifies, nine out of ten times, which spots or lesions (nodules) are benign and malignant on an initial lung computed tomography (CT) scan among individuals at high risk for lung cancer. The findings are expected to have immediate clinical impact worldwide among health professionals who currently diagnose and treat individuals...

2013-06-06 08:30:13

Veran's innovative technology used for the potential early diagnosis of cancer included in ACCP guidelines for establishing the diagnosis of lung cancer ST. LOUIS, June 6, 2013 /PRNewswire/ -- Veran Medical Technologies, the electromagnetic navigation experts and original creator of Always-On Tip Tracked(®) instruments, announced today the launch of SPiNDrive(®) 2.0 software. Veran's SPiNDrive 2.0 is an electromagnetic navigation platform that allows physicians to biopsy...

2012-09-17 13:49:13

In pilot study, authors recommend using larger cohort to validate results A pilot study, published in the October 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed that breath testing could be used to discriminate between benign and malignant pulmonary nodules. The study looked at 74 patients who were under investigation for pulmonary nodules and attended a referral clinic in Colorado between March 2009 and May 2010....

2012-05-15 22:40:03

Authors suggest it could help in preoperative diagnosis along with other methods The most recent research released in June's Journal of Thoracic Oncology says molecular biomarkers in the tissue and fluid lining the lungs might be an additional predictive technique for lung cancer screening. Since the National Lung Screening Trial found that 96.4 percent of the positive CT screening results were false positive, scientists have been looking for ways to more accurately diagnose patients....

2011-12-16 10:43:00

ST. LOUIS, Dec. 16, 2011 /PRNewswire/ -- Veran Medical Technologies announced today the release of its SPiN Drive(TM) platform upgrade for bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously. This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked(TM) instrument in a fluoro-like view without any radiation being delivered to the patient, physician or staff. (Logo:...

2011-07-05 08:00:00

BURLINGTON, Mass., July 5, 2011 /PRNewswire/ -- Tomophase Corporation, developer of the minimally invasive Optical Coherence Tomography Imaging System (OCTIS(TM)) and other devices, announced today that it has received notification from the U.S. Patent and Trademark Office of the issuance of its ninth patent: Integrated Disease Diagnosis and Treatment System, U.S. Patent # 7,970,458. This patent has bearing on major imaging companies such as G.E., Boston Scientific, Johnson and Johnson,...

2011-02-28 13:26:46

European Multidisciplinary Conference in Thoracic Oncology news Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011, Lugano, Switzerland. Dr Luca Bertolaccini, Dr Alberto Terzi and colleagues from Santa Croce e Carle Hospital in Cuneo, Italy, studied a...

2010-06-21 07:00:00

DAYTON, Ohio, June 21 /PRNewswire/ -- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard(TM) Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray (1). This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity...

2009-12-08 08:05:00

ST LOUIS, Dec. 8 /PRNewswire/ -- Veran Medical Technologies announced today that it received clearance (K091934) from the U.S. Food and Drug Administration (FDA) to market a product for the delivery of instruments through the pulmonary tract. "Veran is excited about this clearance as it allows the company to address a huge unmet clinical need in lung cancer diagnosis and treatment," said Jerome R. Edwards, Veran president and chief executive officer. "Leveraging our proprietary IG4...